» Articles » PMID: 35204749

PrimPol: A Breakthrough Among DNA Replication Enzymes and a Potential New Target for Cancer Therapy

Overview
Journal Biomolecules
Publisher MDPI
Date 2022 Feb 25
PMID 35204749
Authors
Affiliations
Soon will be listed here.
Abstract

DNA replication can encounter blocking obstacles, leading to replication stress and genome instability. There are several mechanisms for evading this blockade. One mechanism consists of repriming ahead of the obstacles, creating a new starting point; in humans, PrimPol is responsible for carrying out this task. PrimPol is a primase that operates in both the nucleus and mitochondria. In contrast with conventional primases, PrimPol is a DNA primase able to initiate DNA synthesis de novo using deoxynucleotides, discriminating against ribonucleotides. In vitro, PrimPol can act as a DNA primase, elongating primers that PrimPol itself sythesizes, or as translesion synthesis (TLS) DNA polymerase, elongating pre-existing primers across lesions. However, the lack of evidence for PrimPol polymerase activity in vivo suggests that PrimPol only acts as a DNA primase. Here, we provide a comprehensive review of human PrimPol covering its biochemical properties and structure, in vivo function and regulation, and the processes that take place to fill the gap-containing lesion that PrimPol leaves behind. Finally, we explore the available data on human PrimPol expression in different tissues in physiological conditions and its role in cancer.

Citing Articles

Decoding mitochondrial DNA damage and repair associated with infection.

Shahi A, Kidane D Front Cell Infect Microbiol. 2025; 14:1529441.

PMID: 39906209 PMC: 11790445. DOI: 10.3389/fcimb.2024.1529441.


Canonical and Non-Canonical Roles of Human DNA Polymerase η.

Bedaiwi S, Usmani A, Carty M Genes (Basel). 2024; 15(10).

PMID: 39457395 PMC: 11507097. DOI: 10.3390/genes15101271.


Combined inhibition of RAD51 and CHK1 causes synergistic toxicity in cisplatin resistant cancer cells by triggering replication fork collapse.

Mann J, Niedermayer K, Krautstrunk J, Abbey L, Wiesmuller L, Piekorz R Int J Cancer. 2024; 156(2):389-402.

PMID: 39239809 PMC: 11578078. DOI: 10.1002/ijc.35164.


Transcription-Replication Conflicts as a Source of Genome Instability.

Goehring L, Huang T, Smith D Annu Rev Genet. 2023; 57:157-179.

PMID: 37552891 PMC: 10760935. DOI: 10.1146/annurev-genet-080320-031523.


Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. 2022, , 248.

Diaz-Talavera A, Montero-Conde C, Leandro-Garcia L, Robledo M Biomolecules. 2022; 12(5).

PMID: 35625665 PMC: 9138727. DOI: 10.3390/biom12050693.

References
1.
Sinha N, Morris C, Alberts B . Efficient in vitro replication of double-stranded DNA templates by a purified T4 bacteriophage replication system. J Biol Chem. 1980; 255(9):4290-3. View

2.
Pitcher R, Brissett N, Picher A, Andrade P, Juarez R, Thompson D . Structure and function of a mycobacterial NHEJ DNA repair polymerase. J Mol Biol. 2006; 366(2):391-405. DOI: 10.1016/j.jmb.2006.10.046. View

3.
McDonald J, Frank E, Plosky B, Rogozin I, Masutani C, Hanaoka F . 129-derived strains of mice are deficient in DNA polymerase iota and have normal immunoglobulin hypermutation. J Exp Med. 2003; 198(4):635-43. PMC: 2194173. DOI: 10.1084/jem.20030767. View

4.
Lipps G, Weinzierl A, von Scheven G, Buchen C, Cramer P . Structure of a bifunctional DNA primase-polymerase. Nat Struct Mol Biol. 2004; 11(2):157-62. DOI: 10.1038/nsmb723. View

5.
Taglialatela A, Leuzzi G, Sannino V, Cuella-Martin R, Huang J, Wu-Baer F . REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. Mol Cell. 2021; 81(19):4008-4025.e7. PMC: 8500949. DOI: 10.1016/j.molcel.2021.08.016. View